These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 1810260)

  • 1. Effect of pretreatment with ranitidine on the pharmacokinetics and gastrointestinal transit of a sustained release theophylline preparation.
    Wilson CG; Washington N; Greaves JL; Blackshaw PE; Perkins AC; Barkworth MF; Rehm KD
    Arzneimittelforschung; 1991 Nov; 41(11):1154-9. PubMed ID: 1810260
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The effect of pretreatment with ranitidine on the pharmacokinetics and gastrointestinal transit of a sustained-release theophylline preparation].
    Wilson CG; Washington N; Greaves JL; Blackshaw PE; Perkins AC; Barkworth MF; Rehm KD
    Arzneimittelforschung; 1998 May; 48(5A):561-8. PubMed ID: 9676345
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of cimetidine and ranitidine on the pharmacokinetics of a chronotherapeutically formulated once-daily theophylline preparation (Uniphyl).
    Fraser IM; Buttoo KM; Walker SE; Stewart JH; Babul N
    Clin Ther; 1993; 15(2):383-93. PubMed ID: 8519046
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of gastric pH changes on pharmacokinetic of a sustained-release formulation of theophylline.
    Ferrari M; Olivieri M; Romito D; Biasin C; Barozzi E; Bassetti S
    Riv Eur Sci Med Farmacol; 1991; 13(5-6):269-74. PubMed ID: 1819857
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of food and ranitidine on saquinavir pharmacokinetics and gastric pH in healthy volunteers.
    Kakuda TN; Falcon RW
    Pharmacotherapy; 2006 Aug; 26(8):1060-8. PubMed ID: 16863482
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro and in vivo sustained-release characteristics of theophylline matrix tablets and novel cluster tablets.
    Hayashi T; Kanbe H; Okada M; Kawase I; Ikeda Y; Onuki Y; Kaneko T; Sonobe T
    Int J Pharm; 2007 Aug; 341(1-2):105-13. PubMed ID: 17512147
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics and pharmacodynamics of ranitidine and famotidine in healthy elderly subjects: a double-blind, placebo-controlled comparison.
    Bisson C; St-Laurent M; Michaud JT; LeBel M
    Pharmacotherapy; 1993; 13(1):3-9. PubMed ID: 8437966
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of cilomilast, a selective phosphodiesterase 4 inhibitor, on esophageal motility and pH, and orocecal and colonic transit: two single-center, randomized, double-blind, placebo-controlled, two-part crossover studies in healthy volunteers.
    Houghton LA; Atkinson W; Whorwell PJ; Morris J; Murdoch RD; Cooper SM; Webber DM; Walls CM
    Clin Ther; 2006 Apr; 28(4):569-81. PubMed ID: 16750468
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of raising gastric pH with ranitidine on the absorption and elimination of theophylline from a sustained-release theophylline tablet.
    Betlach CJ; Straughn AB; Meyer MC; Bialer M; Vashi VI; Liebermann P; González MA
    Pharm Res; 1991 Dec; 8(12):1516-9. PubMed ID: 1808616
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Pharmacokinetics of theophylline in sustained-release formulation in young asthmatics].
    Witschital K; Fuchs WS; Heese U; von Nieciecki A; Laicher A
    Arzneimittelforschung; 1998 May; 48(5A):593-6. PubMed ID: 9676351
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HPLC analysis of theophylline: bioequivalence study of two sustained-release formulations at steady state.
    Mazzei M; Sottofattori E; Balbi A; Bottino GB
    Farmaco; 1992 May; 47(5 Suppl):769-77. PubMed ID: 1524625
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Pharmacokinetics of two theophylline sustained-release preparations in healthy humans].
    Keller A; Schulz HU
    Arzneimittelforschung; 1994 Nov; 44(11):1233-6. PubMed ID: 7848337
    [TBL] [Abstract][Full Text] [Related]  

  • 13. H2-antagonist derangement of the kinetics of sustained-release oral theophylline.
    Dal Negro R; Turco P; Zoccatelli O; Trevisan F; Pomart C
    Int J Clin Pharmacol Ther Toxicol; 1985 Jun; 23(6):329-32. PubMed ID: 2862112
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The effect of ranitidine on theophylline pharmacokinetics in patients with obstructive lung disease].
    Paranos S; Despotović N; Vidanović M; Bojović I; Milovanović M; Dmitrović V
    Plucne Bolesti; 1991; 43(1-2):89-93. PubMed ID: 1766997
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differences in steady-state plasma levels between aminophylline and theophylline sustained-release micropellets after repeated circadian dosing.
    Schulz HU; Steinijans VW; Gabel H
    Int J Clin Pharmacol Ther Toxicol; 1984 Nov; 22(11):621-5. PubMed ID: 6500759
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A comparative study of the pharmacokinetics of oral preparations of theophylline].
    Tsoĭ AN; Gneushev ET; Maĭorova EM; Gavrilenko LN; Kunes VG
    Farmakol Toksikol; 1990; 53(5):39-42. PubMed ID: 2253747
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Single dose study of the bioequivalence of two sustained-release theophylline formulations.
    Contreras J; Pérez N; González R; Ontivero E; López M
    Arzneimittelforschung; 1998 Mar; 48(3):259-62. PubMed ID: 9553683
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Absorption profile and absolute bioavailability of a theophylline sustained-release preparation].
    Pabst G; Weber W; Barkworth MF; Müller M; Rehm KD
    Arzneimittelforschung; 1998 May; 48(5A):574-9. PubMed ID: 9676347
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Pharmacokinetics of a theophylline sustained-release formulation after single and twice daily dosage].
    Fuchs WS; von Nieciecki A; Pabst G; Müller M; Dilger C; Gay S; Laicher A; Stanislaus F
    Arzneimittelforschung; 1998 May; 48(5A):589-92. PubMed ID: 9676350
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of single and multiple doses of oral ranitidine on the gastric transit of an indigestible capsule in humans.
    Mojaverian P; Vlasses PH; Parker S; Warner C
    Clin Pharmacol Ther; 1990 Mar; 47(3):382-8. PubMed ID: 2178854
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.